Drugs in HIV and AIDS

Por WISELKA, M.
Publicado em 1999

The Granulomatous Disorders.

Por WISELKA, M
Publicado em 2001

Influenza: diagnosis, management, and prophylaxis.

Por Wiselka, M.
Publicado em 1994

An unusual cause of acute bacterial meningitis

Por Stephenson, I, Wiselka, M
Publicado em 2001

Amantadine for influenza A.

Por Nicholson, K G, Wiselka, M J
Publicado em 1991

Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C

Por Taylor, C, Burns, D, Wiselka, M
Publicado em 2000

Invasive pulmonary aspergillosis complicating chronic obstructive pulmonary disease in an immunocompetent patient.

Por Ali Z, Ali A, Tempest M, Wiselka M
Publicado em 2003-01-01

Dietary intervention in HIV: a comparison of patients receiving oral, enteral and parenteral nutrition.

Por Hewis, H, Palfreeman, A J, Wiselka, M J
Publicado em 1996

Polyarteritis nodosa presenting as a pyrexia of unknown origin

Por Henderson, J, Cohen, J, Jackson, J, Wiselka, M
Publicado em 2002

Still's disease and myocarditis associated with recent mumps infection.

Por Ward, S. C., Wiselka, M. J., Nicholson, K. G.
Publicado em 1988

New World leishmaniasis from Spain

Por Tomson, N, Symonds, R, Moir, A, Kendall, C, Wiselka, M
Publicado em 2002

Fever, weight loss, and night sweats: infection or malignancy? [clinical conference]

Por Winter, A. J., Wiselka, M. J., Wilde, J. T., Radcliffe, K. W.
Publicado em 1998

Impact of respiratory virus infection in patients with chronic chest disease.

Por Wiselka, M. J., Kent, J., Cookson, J. B., Nicholson, K. G.
Publicado em 1993

Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting.

Por Schmid, J, Odds, F C, Wiselka, M J, Nicholson, K G, Soll, D R
Publicado em 1992

Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease.

Por Wiselka, M J, Nicholson, K G, Kent, J, Cookson, J B, Tyrrell, D A
Publicado em 1991

Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients

Por Mohsen, A H, Easterbrook, P J, Taylor, C, Portmann, B, Kulasegaram, R, Murad, S, Wiselka, M, Norris, S
Publicado em 2003

Progressive symptoms and signs following institution of highly active antiretroviral therapy and subsequent antituberculosis therapy: immune reconstitution syndrome or infection?

Por Miller, R F, Shahmanesh, M, Talbot, M D, Wiselka, M J, Shaw, P J, Bacon, C, Robertson, C M
Publicado em 2006